Cargando…

Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications

Renal cell carcinoma (RCC) is one of the most malignant urological tumors. Currently, there is a lack of molecular markers for early diagnosis of RCC. The 5-year survival rate for early-stage RCC is generally favorable; however, the prognosis takes a significant downturn when the tumor progresses to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rui, Rui, Zhou, Liqun, He, Shiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628008/ https://www.ncbi.nlm.nih.gov/pubmed/37942325 http://dx.doi.org/10.3389/fimmu.2023.1271669

Ejemplares similares

Cancer immunotherapies: advances and bottlenecks
por: Rui, Rui, et al.
Publicado: (2023)

Research Progress in the Application of Exosomes in Immunotherapy
por: Zhang, Xiaofang, et al.
Publicado: (2022)

The functions and clinical application potential of exosomes derived from mesenchymal stem cells on wound repair: a review of recent research advances
por: Qin, Xinchi, et al.
Publicado: (2023)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
por: Jian, Yuli, et al.
Publicado: (2021)

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
por: Zhang, Cuijian, et al.
Publicado: (2022)

An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
por: Xu, Huang-Zhen, et al.
Publicado: (2023)

Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression
por: Chen, Zhuang, et al.
Publicado: (2022)

Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases
por: Shen, Ziwei, et al.
Publicado: (2021)

Recent Advances in the Use of Exosomes in Sjögren’s Syndrome
por: Huang, Yupeng, et al.
Publicado: (2020)

Advances in the use of exosomes for the treatment of ALI/ARDS
por: Liu, Chang, et al.
Publicado: (2022)

Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases
por: Zhang, Wenwen, et al.
Publicado: (2023)

Exosomes: A Potential Key Target in Cardio-Renal Syndrome
por: Gonzalez-Calero, Laura, et al.
Publicado: (2014)

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
por: Amin, Asim, et al.
Publicado: (2019)

H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
por: Yu, Sihang, et al.
Publicado: (2022)

The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
por: Jiang, Hao, et al.
Publicado: (2023)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases
por: Li, Jia, et al.
Publicado: (2023)

Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
por: Sequeira, José Pedro, et al.
Publicado: (2021)

Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
por: Lin, Enyu, et al.
Publicado: (2021)

Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021
por: Liu, Kun, et al.
Publicado: (2022)

Research on the biological mechanism and potential application of CEMIP
por: Liu, Yang, et al.
Publicado: (2023)

Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
por: Li, Tanghua, et al.
Publicado: (2023)

Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer
por: He, Danming, et al.
Publicado: (2023)

Exosomes and Autophagy: Coordinated Mechanisms for the Maintenance of Cellular Fitness
por: Baixauli, Francesc, et al.
Publicado: (2014)

The role of hyaluronan in renal cell carcinoma
por: Jin, Chenchen, et al.
Publicado: (2023)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications
por: Liu, Yufei, et al.
Publicado: (2023)

Immunotherapy for EGFR-mutant advanced non-small-cell lung cancer: Current status, possible mechanisms and application prospects
por: Shi, Chunyan, et al.
Publicado: (2022)

The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma
por: Su, Jiaming, et al.
Publicado: (2023)

Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
por: Long, Zhiyong, et al.
Publicado: (2023)

Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases
por: Zhou, Leyu, et al.
Publicado: (2022)

Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
por: Wu, Runda, et al.
Publicado: (2019)

Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist
por: Lu, Yukang, et al.
Publicado: (2023)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

Research progress on the pathogenesis of Graves’ ophthalmopathy: Based on immunity, noncoding RNA and exosomes
por: Zheng, Jingyi, et al.
Publicado: (2022)

Research progress on advanced renal cell carcinoma
por: Song, Xin-da, et al.
Publicado: (2020)

T cell-derived exosomes in tumor immune modulation and immunotherapy
por: Zhou, Qiujun, et al.
Publicado: (2023)

Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma
por: Peng, Ding, et al.
Publicado: (2022)

Application of single-cell sequencing to the research of tumor microenvironment
por: Chen, Sijie, et al.
Publicado: (2023)

Advances of Regulatory B Cells in Autoimmune Diseases
por: Zhu, Qiugang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1kup08h7s6q49jfhq6dpfngudf